Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Ketogenic and Nutritional Interventions for First Episode Bipolar Disorder [NA]
This clinical trial update reports on ketogenic and nutritional interventions for first-episode Bipolar I Disorder and related psychotic con…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Effectiveness of Motivation Skills Training (MST) [NA]
A Columbia University-led clinical trial is evaluating the effectiveness of Motivation Skills Training (MST) for schizophrenia and schizoaff…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Optimizing CBSST With Executive Function Training for Schizophrenia [NA]
This trial update notes ongoing research optimizing CBSST with executive function training for schizophrenia and schizoaffective disorder, w…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Mobile Self-Tracking of Mental Health [NA]
This clinical trial update notes the completion and posting of results for a mobile self-tracking study addressing mental health conditions …
-
CLINICAL_TRIALS other · 2025-10-07Clinical Trial Update: Cognitive Remediation for Coordinated Specialty Care [NA]
A clinical trial investigating cognitive remediation for Coordinated Specialty Care in schizophrenia and schizoaffective disorder is current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Remote State Representation in Early Psychosis [EARLY_Phase 1]
Final update indicating the EARLY_PHASE1 clinical trial on remote state representation in early psychosis has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes [Phase 3]
Phase 3 clinical trial update evaluating methods to estimate and reduce cardiovascular risk in patients with schizophrenia using lipid measu…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Video as a Tool to Improve Insight in Schizophrenia [NA]
This entry notes the completion of a clinical trial evaluating the use of video to improve insight in people with schizophrenia or schizoaff…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
This clinical trial is evaluating whether transcranial direct current stimulation (tDCS) can alter synaptic density in the brains of people …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: State Representation in Early Psychosis
This ClinicalTrials.gov entry describes a University of Minnesota trial on state representation in early psychosis that has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) [Phase 3]
Phase 3 trial evaluating dexmedetomidine for agitation associated with schizophrenia and bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Horyzons: Implementation and Integration in Clinical Practice [NA]
The Horyzons implementation study was terminated and results were posted on 2025-09-18. The trial focused on schizophrenia-spectrum disorder…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy [Phase 2, Phase 3]
A Phase 2/3 clinical trial at Michigan State University is evaluating low amplitude pulse seizure therapy versus standard ultra-brief right …
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Remediation of Visual Perceptual Impairments in People With Schizophrenia [NA]
A completed clinical trial update reports remediation of visual perceptual impairments in individuals with schizophrenia or schizoaffective …
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Young Adults With Violent Behavior During Early Psychosis (Aim 2) [NA]
A Columbia University–sponsored clinical trial update pertains to young adults with violent behavior during early psychosis, covering schizo…
-
FDA approval · 2025-09-04FDA Approved: PALIPERIDONE — Original Application (Eskayef Pharmaceuticals Limited)
FDA approved Eskayef Pharmaceuticals Limited's original application for paliperidone (generic paliperidone). The approval makes a generic ve…
-
FDA approval · 2025-09-03FDA Approved: PALIPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's supplemental application for a generic paliperidone product, expanding access to treatment for schizophrenia and schiz…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: EPI-MINN: Targeting Cognition and Motivation - National [NA]
An update on the EPI-MINN trial from the University of Minnesota evaluating cognition and motivation in several psychotic disorders; the stu…
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents [NA]
A clinical trial from Shanghai Mental Health Center is investigating prediction and intervention effects of rehabilitation status for severe…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use. [NA]
This completed study evaluated the CHAMPION-ECHO educational program to improve clozapine use in schizophrenia and schizoaffective disorder.…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone [Phase 4]
Phase 4 study evaluating high-dose Risperidone long-acting injectable in schizophrenia patients with poor response to risperidone; the trial…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders [NA]
A clinical trial is investigating reduction of anticholinergic medications among persons with schizophrenia or other psychiatric disorders. …
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 clinical trial evaluating whether armodafinil improves cognition in adults with schizophrenia or schizoaffective disorder; the study…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: D-serine AudRem: R33 Phase [Phase 1, Phase 2]
A Phase 1/2 clinical trial of D-serine AudRem (R33) for schizophrenia and schizoaffective disorder is currently suspended.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Effects of RAS in SZ [NA]
Clinical trial update for a study evaluating the effects of RAS in schizophrenia and schizoaffective disorder. The trial status is NOT_YET_R…